These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9549886)

  • 1. A new 5-HT3 receptor ligand. II. Structure-activity analysis of 5-HT3 receptor agonist action in the gut.
    Yamada M; Sato Y; Kobayashi K; Konno F; Soneda T; Watanabe T
    Chem Pharm Bull (Tokyo); 1998 Mar; 46(3):445-51. PubMed ID: 9549886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzoxazole derivatives as novel 5-HT3 receptor partial agonists in the gut.
    Sato Y; Yamada M; Yoshida S; Soneda T; Ishikawa M; Nizato T; Suzuki K; Konno F
    J Med Chem; 1998 Jul; 41(16):3015-21. PubMed ID: 9685241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CP2289, a new 5-HT3 receptor ligand: agonistic activities on gastroenteric motility.
    Sato Y; Imai M; Amano K; Iwamatsu K; Konno F; Kurata Y; Sakakibara S; Hachisu M; Izumi M; Matsuki N; Saito H
    Biol Pharm Bull; 1997 Jul; 20(7):752-5. PubMed ID: 9255414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and pharmacological characterization of a new benzoxazole derivative as a potent 5-HT3 receptor agonist.
    López-Tudanca PL; Labeaga L; Innerárity A; Alonso-Cires L; Tapia I; Mosquera R; Orjales A
    Bioorg Med Chem; 2003 Jul; 11(13):2709-14. PubMed ID: 12788344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species difference in the 5-hydroxytryptamine3 receptor associated with the von Bezold-Jarisch reflex.
    Yamano M; Ito H; Kamato T; Miyata K
    Arch Int Pharmacodyn Ther; 1995; 330(2):177-89. PubMed ID: 8861711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orally active benzoxazole derivative as 5-HT3 receptor partial agonist for treatment of diarrhea-predominant irritable bowel syndrome.
    Yoshida S; Shiokawa S; Kawano K; Ito T; Murakami H; Suzuki H; Sato Y
    J Med Chem; 2005 Nov; 48(22):7075-9. PubMed ID: 16250667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New 2-piperazinylbenzimidazole derivatives as 5-HT3 antagonists. Synthesis and pharmacological evaluation.
    Orjales A; Mosquera R; Labeaga L; Rodes R
    J Med Chem; 1997 Feb; 40(4):586-93. PubMed ID: 9046349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of S 21007 with 5-HT3 receptors. In vitro and in vivo characterization.
    Delagrange P; Emerit MB; Merahi N; Abraham C; Morain P; Rault S; Renard P; Pfeiffer B; Guardiola-Lemaître B; Hamon M
    Eur J Pharmacol; 1996 Dec; 316(2-3):195-203. PubMed ID: 8982686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid receptor-independent inhibition by cannabinoid agonists of the peripheral 5-HT3 receptor-mediated von Bezold-Jarisch reflex.
    Godlewski G; Göthert M; Malinowska B
    Br J Pharmacol; 2003 Mar; 138(5):767-74. PubMed ID: 12642377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definition of a pharmacophore for partial agonists of serotonin 5-HT3 receptors.
    Daveu C; Bureau R; Baglin I; Prunier H; Lancelot JC; Rault S
    J Chem Inf Comput Sci; 1999; 39(2):362-9. PubMed ID: 10192948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
    Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
    Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory molecules for the 5-HT3 receptor ion channel gating system.
    Yoshida S; Watanabe T; Sato Y
    Bioorg Med Chem; 2007 May; 15(10):3515-23. PubMed ID: 17391967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SR 57227A: a potent and selective agonist at central and peripheral 5-HT3 receptors in vitro and in vivo.
    Bachy A; Héaulme M; Giudice A; Michaud JC; Lefevre IA; Souilhac J; Manara L; Emerit MB; Gozlan H; Hamon M
    Eur J Pharmacol; 1993 Jun; 237(2-3):299-309. PubMed ID: 7689975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facilitation by substance P and inhibition by (+)-tubocurarine of the 5-HT3 receptor-mediated Bezold-Jarisch reflex in rats.
    Malinowska B; Godlewski G; Buczko W; Göthert M
    Eur J Pharmacol; 1996 Nov; 315(2):159-64. PubMed ID: 8960879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New thiazole derivatives as potent and selective 5-hydroxytriptamine 3 (5-HT3) receptor agonists for the treatment of constipation.
    Imanishi N; Iwaoka K; Koshio H; Nagashima SY; Kazuta K; Ohta M; Sakamoto S; Ito H; Akuzawa S; Kiso T; Tsukamoto S; Mase T
    Bioorg Med Chem; 2003 Apr; 11(7):1493-502. PubMed ID: 12628674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships for the binding of arylpiperazines and arylbiguanides at 5-HT3 serotonin receptors.
    Dukat M; Abdel-Rahman AA; Ismaiel AM; Ingher S; Teitler M; Gyermek L; Glennon RA
    J Med Chem; 1996 Sep; 39(20):4017-26. PubMed ID: 8831767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of 5-HT3 receptors in the NTS inhibits the cardiac Bezold-Jarisch reflex response.
    Sévoz C; Nosjean A; Callera JC; Machado B; Hamon M; Laguzzi R
    Am J Physiol; 1996 Jul; 271(1 Pt 2):H80-7. PubMed ID: 8760161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed.
    Leurs R; Tulp MT; Menge WM; Adolfs MJ; Zuiderveld OP; Timmerman H
    Br J Pharmacol; 1995 Oct; 116(4):2315-21. PubMed ID: 8564266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzoxazines. II. Synthesis, conformational analysis, and structure--activity relationships of 3,4-dihydro-2H-1,4-benzoxazine-8-carboxamide derivatives as potent and long-acting serotonin-3 (5-HT3) receptor antagonists.
    Kuroita T; Marubayashi N; Sano M; Kanzaki K; Inaba K; Kawakita T
    Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2051-60. PubMed ID: 8945770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel 5-hydroxytryptamine (5-HT3) receptor antagonists. Synthesis and structure-activity relationships of 9-methyl-2,3,4,9-tetrahydrothiopyrano[2,3-b]indol-4-one derivatives.
    Suzuki T; Matsuhisa A; Miyata K; Yanagisawa I; Ohta M
    Chem Pharm Bull (Tokyo); 1997 Jan; 45(1):101-6. PubMed ID: 9023971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.